Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life

Katugampola, Ruwani P.; Huang, Yan; Finlay, A.Y.

doi:10.1111/j.1365-2133.2005.06576.x

Cited by 32 publications

(31 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Physicians make treatment decisions based on their own perception of the disease severity, and often underestimate impact on quality of life by using the degree of cutaneous involvement as a guide. 9 However, the observed change in psoriasis management during the past 20 years indicates that dermatologists are starting to recognize this disparity.…”

Section: Discussionmentioning

confidence: 99%

Increasing use of more potent treatments for psoriasis

Strowd

Yentzer

Fleischer

et al. 2009

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Increasing use of more potent treatments for psoriasis

Strowd

Yentzer

Fleischer

et al. 2009

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…The impact of psoriasis upon quality of life has been extensively investigated, and numerous data have been published in the literature [20,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55]. Indeed, it is now well known that living with psoriasis considerably decreases the quality of life.…”

Section: Discussionmentioning

confidence: 99%

Psoriasis in France and Associated Risk Factors: Results of a Case-Control Study Based on a Large Community Survey

et al. 2008

View full text Add to dashboard Cite

Background: Risk factors for psoriasis have been identified. Objective: To precisely define these associated factors. Methods: A survey was conducted using a questionnaire on a representative sample of the French population. A case-control study was conducted. Cases were persons who declared having had psoriasis during the previous 12 months. For each case, 3 matched controls were selected. Cases and controls were compared using univariate and multivariate analyses. Results: The questionnaire was filled out and returned by 6,887 (68.9%) of 10,000 subjects aged 15 years and over; 356 cases were identified. In multivariate analysis, a higher body mass index, current and former smoking habits and β-blocker intake were independently associated with a higher risk of psoriasis; intake of statins was associated with a decreased risk (p < 0.05). Conclusions: We confirmed the association of overweight, smoking habits and β-blocker intake with psoriasis and reported a decreased risk associated with statin intake.

show abstract

“…The lack of such correlation adds to the clinician’s difficulty in assessment. In a study of management decisions taken in dermatology outpatient clinics concerning patients with psoriasis, overall there was a correlation between the impairment of patient’s QoL and the type of decisions taken [4]. Providing the clinician with information on QoL may therefore help with patient assessment, as well as possibly improving the appropriateness of treatment decision-making.…”

Section: Introductionmentioning

confidence: 99%

The Practical Reality of Using a Patient-Reported Outcome Measure in a Routine Dermatology Clinic

Salek¹,

Roberts²,

Finlay

2007

Dermatology

View full text Add to dashboard Cite

Objective: To explore whether clinicians used formal quality of life (QoL) information if provided by patients completing the Dermatology Life Quality Index (DLQI) questionnaire and whether the information influenced treatment decision-taking. Methods: The DLQI was completed by adult patients attending a dermatology secondary-care clinic as they arrived at their appointment and given to the clinician. Clinicians recorded whether the DLQI information was used and whether it influenced treatment decision-making. Results: A total of 417 patients attended and 268 questionnaires (64.3%) were completed. The mean DLQI score was 7 (median = 5, range = 0–30). In 64 consultations (28.8%), clinicians used the DLQI information; in 37 of these consultations (57.8%) the DLQI information influenced the clinicians’ treatment decision-making. The mean DLQI score for these 37 consultations was 11.3 (median = 10.0, range = 0–29), indicating a large effect on patients’ QoL. QoL discussion occurred in 85 of 98 consultations observed. The domains of QoL most frequently discussed concerned symptoms (74 consultations) and problems caused by the treatment (24 consultations). Conclusions: Clinicians may use formal QoL information if available in routine clinics. Treatment decisions may be influenced for those with high QoL impairment. Routine systematic assessment of QoL may therefore be of benefit.

show abstract

Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life

Abstract: In psoriasis there is a relationship between the type of management decision and the patient-rated QOL. However, there is a very wide score scatter for each management decision, challenging the appropriateness of some clinical decisions.

Cited by 32 publications

References 38 publications

Increasing use of more potent treatments for psoriasis

Increasing use of more potent treatments for psoriasis

Psoriasis in France and Associated Risk Factors: Results of a Case-Control Study Based on a Large Community Survey

The Practical Reality of Using a Patient-Reported Outcome Measure in a Routine Dermatology Clinic

Contact Info

Product

Resources

About